BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7544705)

  • 1. HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients.
    Firdaous I; Hassoun A; Otte JB; Reding R; Squifflet JP; Besse T; Wallemacq PE
    Clin Chem; 1995 Sep; 41(9):1292-6. PubMed ID: 7544705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.
    Salm P; Taylor PJ; Clark A; Balderson GA; Grygotis A; Norris RL; Lynch SV; Shaw LM; Pond SM
    Ther Drug Monit; 1997 Dec; 19(6):694-700. PubMed ID: 9421113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter comparison of first- and second-generation IMx tacrolimus microparticle enzyme immunoassays in liver and kidney transplantation.
    Brunet M; Pou L; Manzanares C; Palacios G; Corbella J
    Ther Drug Monit; 1998 Dec; 20(6):676-9. PubMed ID: 9853987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods.
    Brunet M; Pou L; Torra M; López R; Rodamilans M; Corbella J
    Ther Drug Monit; 1996 Dec; 18(6):706-9. PubMed ID: 8946669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients.
    Salm P; Rutherford DM; Taylor PJ; Black MJ; Pillans PI
    Clin Biochem; 2000 Oct; 33(7):557-62. PubMed ID: 11124341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
    Borrows R; Chusney G; Loucaidou M; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    Ther Drug Monit; 2006 Apr; 28(2):269-73. PubMed ID: 16628143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients.
    Cogill JL; Taylor PJ; Westley IS; Morris RG; Lynch SV; Johnson AG
    Clin Chem; 1998 Sep; 44(9):1942-6. PubMed ID: 9732981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoring.
    Hermida J; Tutor JC
    Clin Lab; 2003; 49(9-10):471-4. PubMed ID: 14572203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
    Napoli KL
    Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfalls in monitoring tacrolimus (FK 506).
    Braun F; Schütz E; Christians U; Lorf T; Schiffmann JH; Armstrong VW; Schröter W; Sewing KF; Oellerich M; Ringe B
    Ther Drug Monit; 1997 Dec; 19(6):628-31. PubMed ID: 9421102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
    Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation.
    Winkler M; Christians U; Baumann J; Gonschior AK; Wonigeit K; Pichlmayr R
    Ther Drug Monit; 1996 Dec; 18(6):640-6. PubMed ID: 8946659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK; Chang HK; Kim HJ; Huh KH; Ahn HJ; Kim MS; Kim SI; Kim YS
    Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus monitoring in renal transplantation: a comparison between high-performance liquid chromatography and immunoassay.
    Borrows R; Chusney G; Loucaidou M; Singh S; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    Transplant Proc; 2005 May; 37(4):1733-5. PubMed ID: 15919448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hematocrit value on microparticle enzyme immunoassay of tacrolimus concentration in therapeutic drug monitoring.
    Tomita T; Homma M; Yuzawa K; Ohkohchi N; Hori T; Kaneko M; Hasegawa Y; Kojima H; Nagasawa T; Kohda Y
    Ther Drug Monit; 2005 Feb; 27(1):94-7. PubMed ID: 15665753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation.
    Bachetoni A; Mariani P; D'Alessandro M; Baiano V; Appodia C; Collepardo D; Berloco P
    Transplant Proc; 2007; 39(6):2008-9. PubMed ID: 17692678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT).
    Bouzas L; Ortega FJ; Casado P; Arranz MI; Carcas A; Tutor JC
    Clin Lab; 2007; 53(9-12):591-6. PubMed ID: 18257466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.